SARS-CoV-2 Continuous Genetic Divergence and Changes in Multiplex RT-PCR Detection Pattern on Positive Retesting Median 150 Days after Initial Infection
Authors:
- Dakai LiuDLDakai Liu
- George D. RodriguezGRGeorge D. Rodriguez
- Hang-Yu ZhouHZHang-Yu Zhou
- Ye-Xiao ChengYCYe-Xiao Cheng
- Xiaofeng LiXLXiaofeng Li
- Wenwen TangWTWenwen Tang
- Nishant PrasadNPNishant Prasad
- Chun-Cheng ChenCCChun-Cheng Chen
- Vishnu SinghVSVishnu Singh
- Eric KonaduEKEric Konadu
- Keither K. JamesKJKeither K. James
- Maria F. BahamonMBMaria F. Bahamon
Open Access
- 2 June 2022
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (11) , 6254
Abstract
Being in the epicenter of the COVID-19 pandemic, our lab tested 193,054 specimens for SARS-CoV-2 RNA by diagnostic multiplex reverse transcription polymerase chain reaction (mRT-PCR) starting in March 2020, of which 17,196 specimens resulted positive. To investigate the dynamics of virus molecular evolution and epidemiology, whole genome amplification (WGA) and Next Generation Sequencing (NGS) were performed on 9516 isolates. 7586 isolates with a high quality were further analyzed for the mutation frequency and spectrum. Lastly, we evaluated the utility of the mRT-PCR detection pattern among 26 reinfected patients with repeat positive testing three months after testing negative from the initial infection. Our results show a continuation of the genetic divergence in viral genomes. Furthermore, our results indicate that independent mutations in the primer and probe regions of the nucleocapsid gene amplicon and envelope gene amplicon accumulate over time. Some of these mutations correlate with the changes of detection pattern of viral targets of mRT-PCR. Our data highlight the significance of a continuous genetic divergence on a gene amplification-based assay, the value of the mRT-PCR detection pattern for complementing the clinical diagnosis of reinfection, and the potential for WGA and NGS to identify mutation hotspots throughout the entire viral genome to optimize the design of the PCR-based gene amplification assay.Keywords
Funding Information
- National key research and development program (2021YFC2301300, 2021-I2M-1-061, 92169106)
- CAMS Innovation Fund for Medical Sciences (2021YFC2301300, 2021-I2M-1-061, 92169106)
- National Natural Science Foundation of China (2021YFC2301300, 2021-I2M-1-061, 92169106)
This publication has 19 references indexed in Scilit:
- Clinical Performance of SARS-CoV-2 Molecular TestsJournal of Clinical Microbiology, 2020
- A new coronavirus associated with human respiratory disease in ChinaNature, 2020
- GISAID: Global initiative on sharing all influenza data – from vision to realityEurosurveillance, 2017
- Data, disease and diplomacy: GISAID's innovative contribution to global healthGlobal Challenges, 2017
- New real-time-PCR method to identify single point mutations in hepatitis C virusWorld Journal of Gastroenterology, 2016
- Single-Nucleotide Polymorphisms and Other Mismatches Reduce Performance of Quantitative PCR AssaysClinical Chemistry, 2013
- MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and UsabilityMolecular Biology and Evolution, 2013
- Molecular Methods and Platforms for Infectious Diseases TestingThe Journal of Molecular Diagnostics, 2011
- The Effect of Primer-Template Mismatches on the Detection and Quantification of Nucleic Acids Using the 5′ Nuclease AssayThe Journal of Molecular Diagnostics, 2010
- Sequence variation in primer targets affects the accuracy of viral quantitative PCRJournal of Clinical Virology, 2005